Dominari Holdings Inc. (DOMH)

Dominari Holdings, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates a broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.

Address

725 FIFTH AVENUE

NEW YORK, NY 10022

Founded

1967

Number of Employees

28

Website

http://www.dominariholdings.com

Buyback

Buyback Data	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
$ Amount Purchased ($ in 000s)	-	-	-	-	-	-	-	-	$57	-	-	$57
Average Price	-	-	-	-	-	-	-	-	$3.16	-	-	$3.16
# Shares Purchased	-	-	-	-	-	-	-	-	18,200	-	-	18,200

Buyback Performance	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
Total Return to Date	-	-	-	-	-	-	-	-	-68.3%	-	-	-68.3%
S&P 500 Return to Date	-	-	-	-	-	-	-	-	37.3%	-	-	37.3%
Excess Total Return	-	-	-	-	-	-	-	-	-105.6%	-	-	-105.6%
Quartile Rank
Percentile Rank	-	-	-	-	-	-	-	-	6%	-	-	8%

Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed

Anebulo Pharmaceuticals, Inc.

WOOL KYLE MICHAEL

Dominari Holdings Inc.